Lawrence Samuel Friedman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroenterology | 11 | 2017 | 536 | 2.190 |
Why?
|
| Liver Diseases | 18 | 2021 | 1253 | 2.030 |
Why?
|
| Gastrointestinal Hemorrhage | 10 | 2008 | 1130 | 0.910 |
Why?
|
| Psychoanalytic Therapy | 2 | 2013 | 230 | 0.770 |
Why?
|
| Liver | 12 | 2017 | 7474 | 0.670 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 337 | 0.640 |
Why?
|
| Liver Failure, Acute | 2 | 2016 | 165 | 0.590 |
Why?
|
| Hares | 1 | 2016 | 4 | 0.590 |
Why?
|
| Turtles | 1 | 2016 | 40 | 0.580 |
Why?
|
| Hepatitis C | 11 | 2015 | 1591 | 0.550 |
Why?
|
| Hepatitis, Viral, Human | 6 | 2010 | 138 | 0.540 |
Why?
|
| Hepatitis A | 4 | 2010 | 133 | 0.530 |
Why?
|
| Hepatitis E | 1 | 2016 | 76 | 0.530 |
Why?
|
| Liver Cirrhosis | 9 | 2021 | 1863 | 0.530 |
Why?
|
| Gift Giving | 1 | 2015 | 80 | 0.520 |
Why?
|
| Hepatitis B virus | 7 | 2004 | 513 | 0.490 |
Why?
|
| Education, Medical | 4 | 2015 | 1721 | 0.470 |
Why?
|
| Health Care Sector | 1 | 2015 | 194 | 0.470 |
Why?
|
| Endoscopy, Gastrointestinal | 7 | 2009 | 868 | 0.460 |
Why?
|
| Liver Transplantation | 11 | 2019 | 2119 | 0.450 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 1179 | 0.450 |
Why?
|
| Simethicone | 1 | 2012 | 15 | 0.450 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2010 | 576 | 0.440 |
Why?
|
| Bisacodyl | 1 | 2012 | 12 | 0.440 |
Why?
|
| Psychoanalytic Theory | 1 | 2013 | 143 | 0.440 |
Why?
|
| Citric Acid | 1 | 2012 | 126 | 0.430 |
Why?
|
| Clinical Medicine | 1 | 2014 | 147 | 0.420 |
Why?
|
| Hepatolenticular Degeneration | 4 | 2010 | 69 | 0.420 |
Why?
|
| Editorial Policies | 1 | 2017 | 451 | 0.410 |
Why?
|
| Lead Poisoning | 1 | 2014 | 301 | 0.410 |
Why?
|
| Cathartics | 1 | 2012 | 125 | 0.410 |
Why?
|
| Colonic Diseases, Functional | 3 | 1996 | 38 | 0.390 |
Why?
|
| Cholestasis | 2 | 2013 | 378 | 0.390 |
Why?
|
| Guidelines as Topic | 3 | 2009 | 1405 | 0.390 |
Why?
|
| Colonoscopy | 4 | 2012 | 1367 | 0.380 |
Why?
|
| Conflict of Interest | 1 | 2015 | 544 | 0.380 |
Why?
|
| Hepatitis B | 7 | 1994 | 695 | 0.370 |
Why?
|
| Abdominal Pain | 2 | 2014 | 1063 | 0.360 |
Why?
|
| Universities | 2 | 2015 | 956 | 0.360 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2018 | 2425 | 0.360 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2010 | 141 | 0.340 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 1855 | 0.330 |
Why?
|
| Lead | 1 | 2014 | 852 | 0.330 |
Why?
|
| Viral Hepatitis Vaccines | 4 | 1993 | 80 | 0.330 |
Why?
|
| Advisory Committees | 2 | 2009 | 775 | 0.320 |
Why?
|
| Aminosalicylic Acids | 4 | 1989 | 37 | 0.320 |
Why?
|
| Liver Circulation | 3 | 2010 | 164 | 0.320 |
Why?
|
| Polyethylene Glycols | 2 | 2015 | 1182 | 0.310 |
Why?
|
| Ethics, Medical | 1 | 2013 | 792 | 0.310 |
Why?
|
| Dyspepsia | 2 | 1999 | 115 | 0.310 |
Why?
|
| Sarcoidosis | 1 | 2013 | 506 | 0.300 |
Why?
|
| Enema | 4 | 1989 | 141 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 6 | 2017 | 7279 | 0.290 |
Why?
|
| Certification | 1 | 2009 | 424 | 0.270 |
Why?
|
| Amyloidosis | 1 | 2013 | 795 | 0.270 |
Why?
|
| Teaching | 1 | 2014 | 1174 | 0.270 |
Why?
|
| Liver Function Tests | 4 | 2016 | 528 | 0.270 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2007 | 194 | 0.270 |
Why?
|
| Anti-Ulcer Agents | 2 | 1998 | 119 | 0.270 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 1432 | 0.260 |
Why?
|
| Myxoma | 1 | 2006 | 130 | 0.260 |
Why?
|
| Helicobacter pylori | 2 | 1999 | 382 | 0.260 |
Why?
|
| Helicobacter Infections | 2 | 1999 | 386 | 0.260 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2011 | 643 | 0.250 |
Why?
|
| Muscle Neoplasms | 1 | 2006 | 139 | 0.250 |
Why?
|
| End Stage Liver Disease | 2 | 2019 | 314 | 0.250 |
Why?
|
| Societies, Medical | 4 | 2009 | 3743 | 0.250 |
Why?
|
| Ambulatory Care | 2 | 2015 | 2708 | 0.250 |
Why?
|
| Travel | 1 | 2010 | 788 | 0.250 |
Why?
|
| Humans | 119 | 2021 | 744343 | 0.240 |
Why?
|
| Anemia, Sickle Cell | 3 | 2013 | 1018 | 0.240 |
Why?
|
| Awards and Prizes | 1 | 2009 | 375 | 0.240 |
Why?
|
| Physician-Patient Relations | 2 | 2019 | 3229 | 0.240 |
Why?
|
| Antidiarrheals | 1 | 2004 | 45 | 0.240 |
Why?
|
| Motivation | 1 | 2013 | 1971 | 0.230 |
Why?
|
| Hepatitis | 3 | 2013 | 227 | 0.220 |
Why?
|
| Diarrhea | 3 | 2004 | 1348 | 0.220 |
Why?
|
| Hepatitis, Alcoholic | 2 | 2017 | 103 | 0.210 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 1239 | 0.200 |
Why?
|
| Peptic Ulcer | 3 | 1994 | 223 | 0.200 |
Why?
|
| Colitis, Ulcerative | 7 | 1999 | 1912 | 0.200 |
Why?
|
| Preoperative Care | 3 | 2009 | 2250 | 0.190 |
Why?
|
| Postoperative Complications | 5 | 2018 | 15295 | 0.180 |
Why?
|
| Colitis | 4 | 1992 | 1170 | 0.180 |
Why?
|
| Hepatitis B, Chronic | 1 | 2004 | 393 | 0.180 |
Why?
|
| Blood Donors | 3 | 1992 | 355 | 0.180 |
Why?
|
| History, 20th Century | 4 | 2015 | 2740 | 0.170 |
Why?
|
| Hemostasis | 1 | 2021 | 458 | 0.160 |
Why?
|
| Sepsis | 1 | 2013 | 2593 | 0.160 |
Why?
|
| Acute Disease | 6 | 2014 | 7149 | 0.160 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 1641 | 0.160 |
Why?
|
| Antifungal Agents | 1 | 2003 | 730 | 0.160 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 814 | 0.160 |
Why?
|
| Omeprazole | 1 | 1998 | 112 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 3 | 2003 | 7181 | 0.160 |
Why?
|
| Hepatovirus | 3 | 1993 | 50 | 0.150 |
Why?
|
| Diagnosis, Differential | 6 | 2016 | 12959 | 0.150 |
Why?
|
| Alanine Transaminase | 4 | 2005 | 592 | 0.150 |
Why?
|
| Autoimmune Diseases | 3 | 2013 | 2133 | 0.150 |
Why?
|
| Disease Management | 2 | 2018 | 2459 | 0.150 |
Why?
|
| Esophagogastric Junction | 1 | 1999 | 313 | 0.140 |
Why?
|
| Orthopedic Procedures | 1 | 2007 | 1288 | 0.140 |
Why?
|
| Hepatitis B Surface Antigens | 5 | 2004 | 305 | 0.140 |
Why?
|
| Biopsy | 3 | 2005 | 6756 | 0.140 |
Why?
|
| Ceruloplasmin | 2 | 1992 | 56 | 0.130 |
Why?
|
| Ultrasonography | 4 | 2016 | 5985 | 0.130 |
Why?
|
| Crohn Disease | 4 | 2018 | 2303 | 0.130 |
Why?
|
| Infertility, Male | 2 | 1989 | 409 | 0.130 |
Why?
|
| Aspartate Aminotransferases | 2 | 2007 | 418 | 0.120 |
Why?
|
| Peritonitis | 2 | 1996 | 365 | 0.120 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 241 | 0.120 |
Why?
|
| Porphyrias | 1 | 2014 | 57 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1992 | 2232 | 0.120 |
Why?
|
| Hypertension, Portal | 1 | 1996 | 220 | 0.120 |
Why?
|
| Attitude | 1 | 2019 | 776 | 0.120 |
Why?
|
| Hepatitis B Antibodies | 4 | 2004 | 159 | 0.120 |
Why?
|
| Palliative Care | 2 | 2019 | 3493 | 0.120 |
Why?
|
| Cholecystitis | 1 | 1994 | 182 | 0.110 |
Why?
|
| Transaminases | 1 | 2014 | 199 | 0.110 |
Why?
|
| Diverticulum, Colon | 1 | 1992 | 33 | 0.110 |
Why?
|
| Vaccines, Inactivated | 1 | 1993 | 184 | 0.110 |
Why?
|
| Jaundice | 2 | 2010 | 89 | 0.110 |
Why?
|
| United States | 13 | 2019 | 69872 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 2 | 1999 | 1876 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 2 | 2015 | 2538 | 0.110 |
Why?
|
| Hepatitis, Chronic | 1 | 1992 | 52 | 0.110 |
Why?
|
| Cryoglobulinemia | 1 | 1992 | 87 | 0.100 |
Why?
|
| Zinc | 2 | 1993 | 684 | 0.100 |
Why?
|
| Listeriosis | 1 | 1992 | 149 | 0.100 |
Why?
|
| Morbidity | 3 | 2008 | 1769 | 0.100 |
Why?
|
| Advance Care Planning | 1 | 2019 | 662 | 0.100 |
Why?
|
| Anemia, Pernicious | 1 | 1991 | 19 | 0.100 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1991 | 49 | 0.100 |
Why?
|
| Interferon-alpha | 2 | 2015 | 895 | 0.100 |
Why?
|
| Pyloric Antrum | 1 | 1991 | 69 | 0.100 |
Why?
|
| Sulfasalazine | 2 | 1989 | 79 | 0.100 |
Why?
|
| Prognosis | 8 | 2014 | 29063 | 0.100 |
Why?
|
| Food Microbiology | 1 | 1991 | 78 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2018 | 1002 | 0.100 |
Why?
|
| Hepatitis D | 2 | 1987 | 18 | 0.100 |
Why?
|
| Spouse Abuse | 1 | 1992 | 178 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2018 | 849 | 0.090 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 248 | 0.090 |
Why?
|
| Male | 32 | 2019 | 350118 | 0.090 |
Why?
|
| Clinical Enzyme Tests | 2 | 1987 | 115 | 0.090 |
Why?
|
| Education, Medical, Graduate | 2 | 2000 | 2291 | 0.090 |
Why?
|
| Isoantibodies | 1 | 2014 | 679 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 1995 | 847 | 0.090 |
Why?
|
| Mycoses | 1 | 2013 | 376 | 0.090 |
Why?
|
| Somatostatin | 1 | 1991 | 459 | 0.090 |
Why?
|
| Microwaves | 1 | 1991 | 191 | 0.090 |
Why?
|
| Colonic Neoplasms | 2 | 1999 | 2541 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2004 | 4245 | 0.090 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2013 | 260 | 0.080 |
Why?
|
| Cyclosporins | 2 | 1989 | 220 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2015 | 1534 | 0.080 |
Why?
|
| Risk Factors | 11 | 2010 | 72290 | 0.080 |
Why?
|
| Disease Outbreaks | 2 | 1991 | 1772 | 0.080 |
Why?
|
| Colorectal Neoplasms | 3 | 2010 | 6773 | 0.080 |
Why?
|
| Intraoperative Period | 1 | 2010 | 520 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 1999 | 1583 | 0.080 |
Why?
|
| Diverticulum | 2 | 1994 | 136 | 0.080 |
Why?
|
| Curriculum | 2 | 2009 | 3605 | 0.080 |
Why?
|
| Autoimmunity | 1 | 1996 | 1349 | 0.080 |
Why?
|
| Sperm-Ovum Interactions | 1 | 1988 | 24 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2014 | 1381 | 0.080 |
Why?
|
| Middle Aged | 22 | 2016 | 213383 | 0.080 |
Why?
|
| Gallstones | 1 | 2010 | 286 | 0.080 |
Why?
|
| Competency-Based Education | 1 | 2009 | 211 | 0.080 |
Why?
|
| Immunity | 1 | 1994 | 1012 | 0.080 |
Why?
|
| Pancreatitis | 2 | 1993 | 1092 | 0.080 |
Why?
|
| Bilirubin | 3 | 2007 | 425 | 0.080 |
Why?
|
| Nausea | 1 | 2010 | 673 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 1999 | 6364 | 0.080 |
Why?
|
| Pruritus | 1 | 2010 | 361 | 0.080 |
Why?
|
| Female | 32 | 2019 | 380194 | 0.070 |
Why?
|
| Mesalamine | 4 | 1989 | 136 | 0.070 |
Why?
|
| Hepatitis C, Chronic | 1 | 2015 | 1031 | 0.070 |
Why?
|
| Hemostatic Techniques | 1 | 2008 | 116 | 0.070 |
Why?
|
| Colon | 2 | 1994 | 1772 | 0.070 |
Why?
|
| Hepatitis B Vaccines | 3 | 1993 | 194 | 0.070 |
Why?
|
| Fatigue | 1 | 2014 | 1531 | 0.070 |
Why?
|
| Survival Rate | 3 | 2008 | 12788 | 0.070 |
Why?
|
| Minnesota | 1 | 2007 | 344 | 0.070 |
Why?
|
| Antiviral Agents | 2 | 2015 | 2987 | 0.070 |
Why?
|
| Pancreas | 1 | 1993 | 1686 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 2 | 2010 | 1071 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 6171 | 0.070 |
Why?
|
| Mesencephalon | 1 | 1987 | 329 | 0.070 |
Why?
|
| Recurrence | 5 | 2005 | 8340 | 0.070 |
Why?
|
| Hepacivirus | 4 | 2015 | 1379 | 0.060 |
Why?
|
| Carcinoma in Situ | 1 | 1991 | 806 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2759 | 0.060 |
Why?
|
| Alkaline Phosphatase | 3 | 2005 | 865 | 0.060 |
Why?
|
| Hepatic Encephalopathy | 2 | 1996 | 139 | 0.060 |
Why?
|
| Abdomen | 1 | 2010 | 1118 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2014 | 2455 | 0.060 |
Why?
|
| Heart Failure | 2 | 2013 | 10900 | 0.060 |
Why?
|
| Anemia | 1 | 2014 | 1506 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2014 | 2240 | 0.060 |
Why?
|
| Lactose Intolerance | 1 | 2004 | 27 | 0.060 |
Why?
|
| Learning | 1 | 2014 | 1713 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2009 | 840 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 1972 | 0.060 |
Why?
|
| Hepatitis B e Antigens | 1 | 2004 | 133 | 0.060 |
Why?
|
| Jejunal Diseases | 1 | 1984 | 50 | 0.060 |
Why?
|
| Lymphoma | 1 | 2013 | 1877 | 0.060 |
Why?
|
| 4-Quinolones | 1 | 2003 | 25 | 0.060 |
Why?
|
| Ascites | 2 | 1996 | 344 | 0.060 |
Why?
|
| Sex Distribution | 2 | 1999 | 2297 | 0.060 |
Why?
|
| Nitrofurantoin | 1 | 2003 | 19 | 0.060 |
Why?
|
| Hepatitis Antibodies | 4 | 1994 | 73 | 0.060 |
Why?
|
| Fabry Disease | 1 | 1984 | 90 | 0.060 |
Why?
|
| RNA, Viral | 3 | 2015 | 2902 | 0.060 |
Why?
|
| Graft Rejection | 2 | 2014 | 4397 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2010 | 1486 | 0.060 |
Why?
|
| Attitude to Health | 1 | 1992 | 2052 | 0.050 |
Why?
|
| Age Distribution | 2 | 1999 | 2902 | 0.050 |
Why?
|
| Tetracycline | 1 | 2003 | 214 | 0.050 |
Why?
|
| Physical Examination | 2 | 2005 | 1237 | 0.050 |
Why?
|
| Collagen | 1 | 1991 | 2689 | 0.050 |
Why?
|
| Age Factors | 4 | 2008 | 18370 | 0.050 |
Why?
|
| Vaccination | 2 | 1991 | 3278 | 0.050 |
Why?
|
| Health Services Research | 1 | 2010 | 1836 | 0.050 |
Why?
|
| Cephalosporins | 1 | 2003 | 204 | 0.050 |
Why?
|
| Chronic Disease | 5 | 1996 | 9146 | 0.050 |
Why?
|
| Macrolides | 1 | 2003 | 201 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1738 | 0.050 |
Why?
|
| Intestinal Perforation | 1 | 1984 | 253 | 0.050 |
Why?
|
| Problem-Based Learning | 1 | 2005 | 361 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 1991 | 1333 | 0.050 |
Why?
|
| Aged | 15 | 2015 | 163280 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2015 | 63114 | 0.050 |
Why?
|
| Virus Replication | 2 | 2004 | 2534 | 0.050 |
Why?
|
| Stents | 1 | 1993 | 3280 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 2031 | 0.050 |
Why?
|
| Adult | 21 | 2015 | 214055 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2018 | 23338 | 0.050 |
Why?
|
| Penicillins | 1 | 2003 | 380 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2015 | 4371 | 0.050 |
Why?
|
| Dopamine | 1 | 1987 | 1591 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2000 | 5788 | 0.040 |
Why?
|
| Clinical Competence | 1 | 1995 | 4687 | 0.040 |
Why?
|
| Vaccines, Synthetic | 2 | 1993 | 634 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 1831 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 2212 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 35421 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2004 | 494 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 1986 | 1826 | 0.040 |
Why?
|
| Incidence | 2 | 2010 | 20947 | 0.040 |
Why?
|
| Anaphylaxis | 1 | 1985 | 746 | 0.040 |
Why?
|
| Rural Health | 1 | 1999 | 305 | 0.040 |
Why?
|
| Hepatitis Delta Virus | 2 | 1987 | 18 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2004 | 2225 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 15540 | 0.040 |
Why?
|
| Endoscopes | 1 | 1998 | 175 | 0.040 |
Why?
|
| Patient Selection | 1 | 2009 | 4215 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2015 | 6489 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2008 | 57776 | 0.040 |
Why?
|
| Urban Health | 1 | 1999 | 547 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 1991 | 3079 | 0.030 |
Why?
|
| North America | 1 | 2000 | 1249 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2009 | 10252 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 1999 | 4253 | 0.030 |
Why?
|
| Hepatorenal Syndrome | 1 | 1996 | 61 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2019 | 289 | 0.030 |
Why?
|
| Bile Ducts | 2 | 1994 | 284 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 1026 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2010 | 3086 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 972 | 0.030 |
Why?
|
| Pyridines | 1 | 1987 | 2825 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4567 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1991 | 4034 | 0.030 |
Why?
|
| Antitubercular Agents | 1 | 2003 | 1320 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2019 | 692 | 0.030 |
Why?
|
| Heart Arrest | 1 | 1985 | 1470 | 0.030 |
Why?
|
| Time Factors | 4 | 2019 | 40075 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 1999 | 494 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2010 | 3537 | 0.030 |
Why?
|
| Prostaglandins, Synthetic | 1 | 1994 | 21 | 0.030 |
Why?
|
| Cholecystostomy | 1 | 1994 | 46 | 0.030 |
Why?
|
| Terpenes | 1 | 1994 | 98 | 0.030 |
Why?
|
| Meckel Diverticulum | 1 | 1994 | 34 | 0.030 |
Why?
|
| Bismuth | 1 | 1994 | 29 | 0.030 |
Why?
|
| Mass Screening | 1 | 2010 | 5255 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 1994 | 91 | 0.030 |
Why?
|
| Air | 1 | 1994 | 182 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 7023 | 0.030 |
Why?
|
| Hepatitis A Vaccines | 1 | 1993 | 29 | 0.030 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1993 | 51 | 0.030 |
Why?
|
| Duodenal Ulcer | 1 | 1993 | 125 | 0.030 |
Why?
|
| Mesenteric Arteries | 1 | 1994 | 183 | 0.030 |
Why?
|
| HIV-1 | 1 | 1991 | 6939 | 0.030 |
Why?
|
| Stomach Ulcer | 1 | 1993 | 125 | 0.030 |
Why?
|
| Ischemia | 1 | 2002 | 1907 | 0.030 |
Why?
|
| Ribavirin | 1 | 2015 | 395 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2003 | 1938 | 0.030 |
Why?
|
| Metallothionein | 1 | 1993 | 59 | 0.030 |
Why?
|
| Adenoma | 1 | 1984 | 2174 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 1993 | 86 | 0.030 |
Why?
|
| Intussusception | 1 | 1994 | 115 | 0.030 |
Why?
|
| Trientine | 1 | 1992 | 11 | 0.030 |
Why?
|
| Ampicillin | 1 | 1992 | 139 | 0.030 |
Why?
|
| Colectomy | 1 | 1998 | 683 | 0.030 |
Why?
|
| Zinc Sulfate | 1 | 1992 | 17 | 0.030 |
Why?
|
| Ulcer | 1 | 1994 | 209 | 0.030 |
Why?
|
| Rectal Diseases | 1 | 1994 | 143 | 0.030 |
Why?
|
| Penicillamine | 1 | 1992 | 59 | 0.030 |
Why?
|
| Hepatitis B Core Antigens | 1 | 1992 | 92 | 0.030 |
Why?
|
| Animals | 5 | 2016 | 168757 | 0.030 |
Why?
|
| Varicose Veins | 1 | 1994 | 154 | 0.030 |
Why?
|
| Colonic Diseases | 1 | 1994 | 202 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 1993 | 504 | 0.030 |
Why?
|
| HIV Seroprevalence | 1 | 1992 | 86 | 0.030 |
Why?
|
| Copper Radioisotopes | 1 | 1992 | 86 | 0.030 |
Why?
|
| Immunoblotting | 2 | 1992 | 1682 | 0.030 |
Why?
|
| Ophthalmoscopy | 1 | 1992 | 176 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 39050 | 0.030 |
Why?
|
| Anemia, Hypochromic | 1 | 1991 | 66 | 0.020 |
Why?
|
| Cryptosporidiosis | 1 | 1991 | 60 | 0.020 |
Why?
|
| Appetite | 1 | 1993 | 243 | 0.020 |
Why?
|
| Tennessee | 1 | 1991 | 117 | 0.020 |
Why?
|
| Sulfates | 1 | 1992 | 390 | 0.020 |
Why?
|
| Intestinal Mucosa | 2 | 1993 | 3036 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2015 | 77449 | 0.020 |
Why?
|
| Research Report | 1 | 2014 | 355 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 1996 | 4149 | 0.020 |
Why?
|
| Vasculitis | 1 | 1994 | 519 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 1991 | 520 | 0.020 |
Why?
|
| Copper | 1 | 1992 | 366 | 0.020 |
Why?
|
| Food Preferences | 1 | 1993 | 399 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 1991 | 919 | 0.020 |
Why?
|
| Running | 1 | 1994 | 480 | 0.020 |
Why?
|
| Child | 5 | 2007 | 77709 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 1992 | 345 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 1994 | 530 | 0.020 |
Why?
|
| Diverticulitis, Colonic | 1 | 1990 | 128 | 0.020 |
Why?
|
| Catheterization | 1 | 1994 | 1470 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 1989 | 211 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14722 | 0.020 |
Why?
|
| Drainage | 1 | 1994 | 1142 | 0.020 |
Why?
|
| Restaurants | 1 | 1991 | 236 | 0.020 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 1987 | 30 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 25043 | 0.020 |
Why?
|
| Neurons | 1 | 1987 | 9338 | 0.020 |
Why?
|
| Anesthesia | 1 | 1999 | 1561 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1987 | 96 | 0.020 |
Why?
|
| Israel | 1 | 1990 | 796 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1996 | 2035 | 0.020 |
Why?
|
| Pyridinium Compounds | 1 | 1987 | 84 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1987 | 218 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 19905 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1999 | 2214 | 0.020 |
Why?
|
| Random Allocation | 2 | 1993 | 2429 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1994 | 1180 | 0.020 |
Why?
|
| Viral Load | 1 | 2015 | 3299 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 780 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1987 | 719 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1987 | 375 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3528 | 0.020 |
Why?
|
| Gardner Syndrome | 1 | 1985 | 4 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 1992 | 956 | 0.020 |
Why?
|
| Hepatitis A Antibodies | 1 | 1985 | 18 | 0.020 |
Why?
|
| Endometriosis | 1 | 1994 | 839 | 0.020 |
Why?
|
| Sigmoidoscopy | 1 | 1986 | 156 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1995 | 1786 | 0.020 |
Why?
|
| Occult Blood | 1 | 1986 | 176 | 0.020 |
Why?
|
| HIV Infections | 1 | 1992 | 16718 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 1991 | 605 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1991 | 1125 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1993 | 2017 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 1999 | 7785 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 3176 | 0.020 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1985 | 111 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3843 | 0.020 |
Why?
|
| Ampulla of Vater | 1 | 1985 | 141 | 0.020 |
Why?
|
| Communication | 1 | 2019 | 3749 | 0.020 |
Why?
|
| South Africa | 1 | 1990 | 1731 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1986 | 647 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3870 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 419 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1992 | 3913 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 56430 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 8642 | 0.020 |
Why?
|
| Forecasting | 1 | 1993 | 2951 | 0.020 |
Why?
|
| Educational Status | 1 | 1992 | 2540 | 0.010 |
Why?
|
| Ranitidine | 1 | 1983 | 34 | 0.010 |
Why?
|
| Epitopes | 1 | 1991 | 2571 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 11031 | 0.010 |
Why?
|
| Intestines | 1 | 1993 | 1924 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1993 | 2282 | 0.010 |
Why?
|
| Europe | 1 | 1990 | 3339 | 0.010 |
Why?
|
| Serologic Tests | 1 | 1985 | 374 | 0.010 |
Why?
|
| Liver Cirrhosis, Biliary | 2 | 1994 | 97 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 13881 | 0.010 |
Why?
|
| Endoscopy | 1 | 1993 | 1785 | 0.010 |
Why?
|
| Prevalence | 2 | 2010 | 15226 | 0.010 |
Why?
|
| Patient Participation | 1 | 1992 | 1457 | 0.010 |
Why?
|
| Data Collection | 1 | 1992 | 3341 | 0.010 |
Why?
|
| Rectum | 1 | 1987 | 904 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1992 | 2057 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1987 | 2187 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1990 | 1401 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1984 | 564 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1994 | 5391 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1989 | 2382 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1984 | 1185 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 12951 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1985 | 1537 | 0.010 |
Why?
|
| Colonic Polyps | 1 | 1985 | 542 | 0.010 |
Why?
|
| Abscess | 1 | 1984 | 607 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1995 | 4251 | 0.010 |
Why?
|
| Adolescent | 4 | 1994 | 85781 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2010 | 2616 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1992 | 3444 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1987 | 4933 | 0.010 |
Why?
|
| Boston | 1 | 1992 | 9313 | 0.010 |
Why?
|
| Angiography | 1 | 1984 | 1639 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2009 | 2265 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3610 | 0.010 |
Why?
|
| Quality of Life | 1 | 1999 | 12804 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 1993 | 12026 | 0.010 |
Why?
|
| Diet | 1 | 1994 | 7939 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1993 | 53288 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1992 | 15076 | 0.010 |
Why?
|
| Rats | 2 | 1993 | 24260 | 0.010 |
Why?
|
| Cyclohexenes | 1 | 1994 | 15 | 0.010 |
Why?
|
| Risk | 1 | 1987 | 9687 | 0.010 |
Why?
|
| Citrus | 1 | 1994 | 41 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1987 | 3966 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1994 | 361 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1993 | 370 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1985 | 4560 | 0.010 |
Why?
|
| Breath Tests | 1 | 1994 | 280 | 0.010 |
Why?
|
| Hydrogen Sulfide | 1 | 1994 | 137 | 0.010 |
Why?
|
| Ligation | 1 | 1993 | 453 | 0.010 |
Why?
|
| Massachusetts | 1 | 1985 | 8663 | 0.010 |
Why?
|
| Cholangitis | 1 | 1993 | 108 | 0.010 |
Why?
|
| Taste | 1 | 1993 | 176 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1987 | 19229 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1994 | 676 | 0.010 |
Why?
|
| Smell | 1 | 1993 | 244 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1986 | 7913 | 0.010 |
Why?
|
| Obesity | 2 | 1991 | 12745 | 0.010 |
Why?
|
| Infant | 1 | 1991 | 35136 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1991 | 41006 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1988 | 25625 | 0.000 |
Why?
|
| Mutation | 1 | 1991 | 29786 | 0.000 |
Why?
|
| Pregnancy | 1 | 1988 | 29144 | 0.000 |
Why?
|
| Energy Intake | 1 | 1993 | 2148 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1993 | 6365 | 0.000 |
Why?
|
| Cimetidine | 1 | 1983 | 78 | 0.000 |
Why?
|
| Gastric Acid | 1 | 1983 | 104 | 0.000 |
Why?
|
| Esophagitis, Peptic | 1 | 1983 | 78 | 0.000 |
Why?
|
| Weight Gain | 1 | 1993 | 2292 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8301 | 0.000 |
Why?
|
| Feeding Behavior | 1 | 1994 | 3188 | 0.000 |
Why?
|
| Alcoholism | 1 | 1991 | 1906 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1983 | 1609 | 0.000 |
Why?
|
| Kinetics | 1 | 1983 | 6473 | 0.000 |
Why?
|